Notice of Correction to RFA-AR-24-001, "NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)"
Notice Number:
NOT-AR-23-013

Key Dates

Release Date:

January 20, 2023

Related Announcements

RFA-AR-24-001 - NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)

Issued by

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

The purpose of this Notice is to inform applicants of a correction to Additional Information on Eligibility for RFA-AR-24-001, “NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)”. Changes to the Funding Opportunity Announcement (FOA) are shown below.

The following section of RFA-AR-24-001 has been corrected:

3. Additional Information on Eligibility

Currently Reads:

Number of Applications

Please change to “Only one application per institution (normally identified by having a unique entity identifier (UEI) number or NIH IPF number) is allowed."

Applicant organizations may submit more than one application, provided that each application is scientifically distinct.

Modified to Read (changes shown in bold italics):

Number of Applications

Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Aron Marquitz, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-435-1240
Email: [email protected]